PubMed Health⌕ Search

PubMed · 8746499

Tracing the planned probe trajectory on axial computed tomography slices: a computation-based support for stereotactic procedures. A computational tool for tracing of probe trajectories on CT slices.

Abstract

Stereotactic frames are designed to hit point-like intracranial targets. Their routine performance does not include a display of the intended transcerebral probe path. Since the latter can render stereotactic procedures safer, more accurate and versatile, it has increasingly been implemented by potent computer systems. A low-cost alternative is presented in the form of a small extension of the computation program which is usually employed for the conversion of imaging coordinates to frame adjustments. It allows any desired point on the planned probe trajectory, in terms of its distance to the target, to be defined in Cartesian coordinates and thus to be traced on computed tomography. Thus, in biopsy procedures, for instance, instead of sampling tissue at the target only or in a 'blind' serial way, samples can be collected in a previewed and therefore safer and more purposeful way, thereby improving the yield of pathological tissue. The method seems particularly interesting for institutions that have a low to moderate number of stereotactic procedures and for which the investment of sophisticated computer systems for this purpose alone would not be economically feasible.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D Van Roost. 1995. Tracing the planned probe trajectory on axial computed tomography slices: a computation-based support for stereotactic procedures. A computational tool for tracing of probe trajectories on CT slices.. https://doi.org/10.1159/000098739

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

BACKGROUND: In fair-skinned Caucasian populations both the incidence and mortality rates of cutaneous melanoma have been increasing over the past decades. With adjuvant therapies still being under investigation, early detection is the only way to improve melanoma patient survival. The influence of incisional biopsies on melanoma patient survival has been discussed for many years. This study investigates both the influence of diagnostic biopsy type and the presence of residual tumor cells in the re-excision specimen on disease free and overall survival. METHODS: After (partial) removal of a pigmented skin lesion 471 patients were diagnosed with stage I/II melanoma and underwent re-excision and a sentinel node biopsy. All patients were followed prospectively, mean follow up >5 years. Patients were divided according to their diagnostic biopsy type (wide excision biopsy, narrow excision biopsy, excision biopsy with positive margins and incisional biopsy) and the presence of residual tumor cells in their re-excision specimen. Survival analysis was done using Cox's proportional hazard model adjusted for eight important confounders of melanoma patient survival. RESULTS: The diagnostic biopsy was wide in 279 patients, narrow in 109 patients, 52 patients underwent an excision biopsy with positive margins and 31 patients an incisional biopsy. In 41 patients residual tumor cells were present in the re-excision specimen. Both the diagnostic biopsy type and the presence of tumor cells in the re-excision specimen did not influence disease free and overall survival of melanoma patients. CONCLUSIONS: Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

Biopsy↗